Shopping Cart (0)
My Account

 Shopping Cart
Conferences | Training Courses | Market Reports | Managed Events | Past Conferences | Update Me
SELECTBIO Conferences Fragment Based Lead Discovery
Conferences  \  Discovery Chemistry Congress  \  Fragment Based Lead Discovery   \  Agenda  \  Thierry Langer
RegisterLogin

Thierry Langer's Biography


Thierry Langer, CEO, Prestwick Chemical

Thierry Langer is full professor and head of the department of Pharmaceutical Chemistry at University of Vienna, Austria. Before that, he was CEO of Prestwick Chemical, France. He is author of more than 170 original papers and has long term expertise in computational medicinal chemistry. He is also the coordinator of the Austrian academic drug discovery
initiative wings4innovation (www.w4i.org).

 Thierry Langer Image

Medicinal Chemistry Guided by in silico Fragment Screening: Efficient Discovery of New Lead Compounds

Wednesday, 20 March 2013 at 15:45

Add to Calendar ▼2013-03-20 15:45:002013-03-20 16:45:00Europe/LondonMedicinal Chemistry Guided by in silico Fragment Screening: Efficient Discovery of New Lead CompoundsSELECTBIOenquiries@selectbiosciences.com

Prof. Langer will showcase the results of a recent research project using pharmacophore-based in silico fragment screening for the discovery of attractive starting points for a medicinal chemistry hit to lead optimization program.

Add to Calendar ▼2013-03-19 00:00:002013-03-20 00:00:00Europe/LondonFragment Based Lead Discovery SELECTBIOenquiries@selectbiosciences.com


Conference Sponsors